awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33416075-DAC90E91-63BB-454F-8FCA-D77C713AF54C
Q33416075-DAC90E91-63BB-454F-8FCA-D77C713AF54C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33416075-DAC90E91-63BB-454F-8FCA-D77C713AF54C
A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621.
P2860
Q33416075-DAC90E91-63BB-454F-8FCA-D77C713AF54C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33416075-DAC90E91-63BB-454F-8FCA-D77C713AF54C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0767f1d2bc5a6a842b14ad08da5aa984b2cd5bf1
P2860
A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (